ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: SA-PO209

Risk Factors for Advanced Colorectal Neoplasia in CKD

Session Information

  • Onco-Nephrology: Clinical
    November 09, 2019 | Location: Exhibit Hall, Walter E. Washington Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Onco-Nephrology

  • 1500 Onco-Nephrology

Author

  • Au, Eric Hoi Kit, University of Sydney, Sydney, New South Wales, Australia

Group or Team Name

  • DETECT Study Investigators
Background

Colorectal cancer is common in people with chronic kidney disease (CKD), but the risk factors are poorly understood. The aim of this study is to identify risk factors for advanced colorectal neoplasia in people with CKD (as a sub-study of DETECT).

Methods

People with CKD (stages III-V, dialysis and transplant) across eleven sites in Australia, New Zealand, Canada and Spain were screened for colorectal neoplasm using fecal immunochemical test (FIT). Advanced colorectal neoplasia was identified through a 2-step verification process with colonoscopy following a positive FIT and 2-year clinical follow-up for all patients. Potential risk factors for advanced colorectal neoplasia at different CKD stages were assessed using multivariable logistic regression.

Results

A total of 1706 patients received FIT screening (791 CKD III-V, 418 dialysis, 497 transplant). 323 (18.9%) had colonoscopy for positive FIT and 103 advanced colorectal neoplasia (44 CKD III-V, 31 dialysis, 28 transplant) were identified (overall detection rate 6%). At follow-up, 14 additional advanced neoplasia (10 CKD III-V, 3 dialysis, 1 transplant) were identified. Across CKD stages, older age and male sex were risk factors for advanced colorectal neoplasia (figure). Current smoking use was associated with advanced colorectal neoplasia among those with CKD III-V [odds ratio 2.3 (95% CI 1.1-4.9)]. For those on dialysis, patients with diabetes experienced 2.1 times greater odds of advanced colorectal neoplasia (95% CI 1.0-4.4). For kidney transplant recipients, daily anticoagulant use was associated with increased odds of advanced colorectal neoplasia [OR 4.5 (95% CI 1.5-13.4)].

Conclusion

Increasing age, smoking, male sex and having diabetes are associated with advanced colorectal neoplasia in patients with CKD. The observed increased risk associated with anticoagulation use in transplant recipients may be due to increased detection by FIT.

Funding

  • Government Support - Non-U.S.